Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,14%
1 095,39
+1,58
+0,14%
1 093,811 096,521 100,221 093,20
SIXC
Communications
SIXC
Communications
SIXC
+0,34%
610,85
+2,08
+0,34%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,10%
1 240,97
-13,84
-1,10%
1 254,811 253,011 253,871 226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,65%
1 749,74
-11,37
-0,65%
1 761,111 764,271 766,881 745,39
SIXM
Financials
SIXM
Financials
SIXM
-0,07%
642,12
-0,46
-0,07%
642,58644,87648,48641,40
SIXR
Staples
SIXR
Staples
SIXR
-0,22%
849,22
-1,91
-0,22%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,22%
217,49
-0,49
-0,22%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,63%
3 264,23
+52,40
+1,63%
3 211,833 227,213 267,763 226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,48%
944,39
-4,59
-0,48%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,25%
1 470,80
-3,72
-0,25%
1 474,521 479,031 481,041 469,17
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,65%
2 407,56
+15,44
+0,65%
2 392,122 396,952 421,222 382,32
Q1 2026 earnings • released • EPS beat +15,91% • Revenue beat +3,27%
See results
BAX:NYSE
Baxter International Inc
17,27 $
-1,62%
(-0,28) 1D
1 մյս, 15:31:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Open
17,84 $
High
17,85 $
Low
17,04 $
Mkt. cap
8,88 մլրդ
Avg. vol.
8,35 մլն
Volume
6,68 մլն
Dividend
0,23%
Quarterly dividend
0,01 $
Ex dividend date
28 նոյ, 2025 թ.
52-wk high
32,68 $
52-wk low
15,73 $
EPS
-1,75 $
Beta
0,62
Shares outstanding
516,25 մլն
No. of employees
38 հզր
News stories
From sources across the web
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37,5 հզր
Founded1931
HeadquartersDeerfield, Իլինոյս, Միացյալ Նահանգներ
Sector-
Websitebaxter.com
Last report
30 ապր, 2026 թ.
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0,36/ (0,31 est.)USD
+15,91%beat
Revenue / Estimate
2,70 մլրդ/ (2,62 մլրդ est.)USD
+3,27%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
2,62 մլրդ
2,81 մլրդ
2,84 մլրդ
2,97 մլրդ
Cost of goods sold
1,63 մլրդ
1,67 մլրդ
1,81 մլրդ
2,01 մլրդ
Cost of revenue
1,63 մլրդ
1,67 մլրդ
1,81 մլրդ
2,01 մլրդ
Research and development expenses
138,00 մլն
134,00 մլն
115,00 մլն
116,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
648,00 մլն
628,00 մլն
669,00 մլն
675,00 մլն
Operating expense
732,00 մլն
710,00 մլն
734,00 մլն
741,00 մլն
Total operating expenses
2,36 մլրդ
2,38 մլրդ
2,55 մլրդ
2,76 մլրդ
Operating income
262,00 մլն
434,00 մլն
287,00 մլն
219,00 մլն
Other non operating income
2,00 մլն
-1,00 մլն
2,00 մլն
3,00 մլն
EBT including unusual items
-3,00 մլն
133,00 մլն
121,00 մլն
-756,00 մլն
EBT excluding unusual items
200,00 մլն
363,00 մլն
228,00 մլն
161,00 մլն
Income tax expense
-67,00 մլն
11,00 մլն
172,00 մլն
279,00 մլն
Effective tax rate
2 233,33%
8,27%
142,15%
-36,90%
Other operating expenses
-54,00 մլն
-52,00 մլն
-50,00 մլն
-50,00 մլն
Net income
126,00 մլն
91,00 մլն
-46,00 մլն
-1,13 մլրդ
Net profit margin
4,80%
3,24%
-1,62%
-37,93%
Earnings per share
0,55
0,59
0,69
0,44
Interest and investment income
17,00 մլն
14,00 մլն
10,00 մլն
11,00 մլն
Interest expense
-81,00 մլն
-72,00 մլն
-68,00 մլն
-69,00 մլն
Net interest expenses
-64,00 մլն
-58,00 մլն
-58,00 մլն
-58,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
509,00 մլն
691,00 մլն
524,00 մլն
459,00 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more